SingStrong: Strong Lungs Through Song - Long COVID-19 Study (ss)

University of Limerick

Status: Completed

Conditions: Long Covid

Treatments: Other: SingStrong: Strong lungs through Song

Study type: Interventional

Funder types: Other

Identifiers

NCT04810065

SingStrong

Details and patient eligibility

About

Evidence is emerging that many individuals who recover from Covid-19 are experiencing a range of residual problems. These include fatigue, pain, reduced exercise tolerance and breathing issues. This study includes participants who are experiencing problems with their lungs such as breathing difficulties, shortness of breath, and/or reduced exercise tolerance. The intervention is a twice weekly singing and breathing retraining intervention conducted over ten weeks. A range of self-report questionnaire measures will evaluate the efficacy of the intervention in addressing these problems. Focus groups and individual interviews will also be used to gather information on the impact and acceptability of the programme.

Enrollment: 30 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years of age or older
• Previous clinical diagnosis of Covid-19
• Ongoing issues with any or all of: Shortness of breath, disordered breathing, reduced exercise tolerance
• Good written and spoken English language

Exclusion criteria

• Lack of a confirmed Covid-19 diagnosis
• Currently undergoing a similar singing or breathing retraining intervention
• No residual problems from a confirmed case of Covid-19

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

SingStrong for Pulmonary Fibrosis

Other group

Description:

This arm of the project explores Singing as an intervention for people suffering from Pulmonary Fibrosis specifically. It is a 10 week programme. All other aspects of the intervention are the same in terms of delivery and length of classes. Different outcome measures, namely the St Georges Respiratory Questionnaire is used in this trial. This is a disease-specific instrument designed to measure impact on overall health, daily life, and perceived well-being in patients with airways disease. Scores range from 0 to 100, with higher scores indicating more limitations.

Treatment:

Other: SingStrong: Strong lungs through Song